PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (CERATOTHERIUM SIMUM)

Brittni East, Lisa A Tell, Scott B. Citino, Daniel V. Fredholm, Kathryn Gamble, Virginia Fajt

Research output: Contribution to journalArticle

Abstract

Flunixin meglumine, a nonsteroidal anti-inflammatory medication, has been used in rhinoceros species at doses extrapolated from domestic animals. There is increasing evidence to suggest significant variations exist in metabolism of drugs in exotic species. Due to the differences in drug metabolism, dose extrapolation from domestic animals may not be appropriate for exotic species. The objective of this study was to investigate the pharmacokinetics of flunixin meglumine in five white rhinoceroses (Ceratotherium simum) administered a single (1 mg/kg) oral dose of a commercial equine flunixin meglumine paste. Concentrations of flunixin and its metabolite 5-OH flunixin were analyzed, and pharmacokinetic parameters were estimated for each animal. Mean observed plasma concentrations peaked at 1,207 ± 601 ng/ml and occurred at 3 ± 1 hr. The geometric mean of the apparent elimination half-life after oral administration was 8.3 ± 1.2 hr. This data suggests that flunixin meglumine appears to be slowly metabolized or slowly absorbed in this species. No adverse clinical effects were observed during the study period. A single dose of 1 mg/kg appears safe for use in the white rhinoceros. Multidose studies are needed to determine if plasma accumulation of flunixin meglumine occurs and to evaluate safety.

Original languageEnglish (US)
Pages (from-to)322-329
Number of pages8
JournalJournal of Zoo and Wildlife Medicine
Volume50
Issue number2
DOIs
StatePublished - Jun 1 2019

Fingerprint

flunixin
pharmacokinetics
mouth
Pharmacokinetics
dosage
Domestic Animals
domestic animals
Ointments
Pharmaceutical Preparations
Horses
Rhinoceros
Oral Administration
Half-Life
Anti-Inflammatory Agents
Ceratotherium simum
flunixin meglumine
oral administration
Safety
drug therapy
half life

Keywords

  • 5-OH flunixin
  • Ceratotherium simum
  • flunixin meglumine
  • pharmacokinetics
  • white rhinoceros

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)

Cite this

PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (CERATOTHERIUM SIMUM). / East, Brittni; Tell, Lisa A; Citino, Scott B.; Fredholm, Daniel V.; Gamble, Kathryn; Fajt, Virginia.

In: Journal of Zoo and Wildlife Medicine, Vol. 50, No. 2, 01.06.2019, p. 322-329.

Research output: Contribution to journalArticle

East, Brittni ; Tell, Lisa A ; Citino, Scott B. ; Fredholm, Daniel V. ; Gamble, Kathryn ; Fajt, Virginia. / PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (CERATOTHERIUM SIMUM). In: Journal of Zoo and Wildlife Medicine. 2019 ; Vol. 50, No. 2. pp. 322-329.
@article{9372c2d4a74a4eb087563c935546c956,
title = "PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (CERATOTHERIUM SIMUM)",
abstract = "Flunixin meglumine, a nonsteroidal anti-inflammatory medication, has been used in rhinoceros species at doses extrapolated from domestic animals. There is increasing evidence to suggest significant variations exist in metabolism of drugs in exotic species. Due to the differences in drug metabolism, dose extrapolation from domestic animals may not be appropriate for exotic species. The objective of this study was to investigate the pharmacokinetics of flunixin meglumine in five white rhinoceroses (Ceratotherium simum) administered a single (1 mg/kg) oral dose of a commercial equine flunixin meglumine paste. Concentrations of flunixin and its metabolite 5-OH flunixin were analyzed, and pharmacokinetic parameters were estimated for each animal. Mean observed plasma concentrations peaked at 1,207 ± 601 ng/ml and occurred at 3 ± 1 hr. The geometric mean of the apparent elimination half-life after oral administration was 8.3 ± 1.2 hr. This data suggests that flunixin meglumine appears to be slowly metabolized or slowly absorbed in this species. No adverse clinical effects were observed during the study period. A single dose of 1 mg/kg appears safe for use in the white rhinoceros. Multidose studies are needed to determine if plasma accumulation of flunixin meglumine occurs and to evaluate safety.",
keywords = "5-OH flunixin, Ceratotherium simum, flunixin meglumine, pharmacokinetics, white rhinoceros",
author = "Brittni East and Tell, {Lisa A} and Citino, {Scott B.} and Fredholm, {Daniel V.} and Kathryn Gamble and Virginia Fajt",
year = "2019",
month = "6",
day = "1",
doi = "10.1638/2018-0200",
language = "English (US)",
volume = "50",
pages = "322--329",
journal = "Journal of Zoo and Wildlife Medicine",
issn = "1042-7260",
publisher = "American Association of Zoo Veterinarians",
number = "2",

}

TY - JOUR

T1 - PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (CERATOTHERIUM SIMUM)

AU - East, Brittni

AU - Tell, Lisa A

AU - Citino, Scott B.

AU - Fredholm, Daniel V.

AU - Gamble, Kathryn

AU - Fajt, Virginia

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Flunixin meglumine, a nonsteroidal anti-inflammatory medication, has been used in rhinoceros species at doses extrapolated from domestic animals. There is increasing evidence to suggest significant variations exist in metabolism of drugs in exotic species. Due to the differences in drug metabolism, dose extrapolation from domestic animals may not be appropriate for exotic species. The objective of this study was to investigate the pharmacokinetics of flunixin meglumine in five white rhinoceroses (Ceratotherium simum) administered a single (1 mg/kg) oral dose of a commercial equine flunixin meglumine paste. Concentrations of flunixin and its metabolite 5-OH flunixin were analyzed, and pharmacokinetic parameters were estimated for each animal. Mean observed plasma concentrations peaked at 1,207 ± 601 ng/ml and occurred at 3 ± 1 hr. The geometric mean of the apparent elimination half-life after oral administration was 8.3 ± 1.2 hr. This data suggests that flunixin meglumine appears to be slowly metabolized or slowly absorbed in this species. No adverse clinical effects were observed during the study period. A single dose of 1 mg/kg appears safe for use in the white rhinoceros. Multidose studies are needed to determine if plasma accumulation of flunixin meglumine occurs and to evaluate safety.

AB - Flunixin meglumine, a nonsteroidal anti-inflammatory medication, has been used in rhinoceros species at doses extrapolated from domestic animals. There is increasing evidence to suggest significant variations exist in metabolism of drugs in exotic species. Due to the differences in drug metabolism, dose extrapolation from domestic animals may not be appropriate for exotic species. The objective of this study was to investigate the pharmacokinetics of flunixin meglumine in five white rhinoceroses (Ceratotherium simum) administered a single (1 mg/kg) oral dose of a commercial equine flunixin meglumine paste. Concentrations of flunixin and its metabolite 5-OH flunixin were analyzed, and pharmacokinetic parameters were estimated for each animal. Mean observed plasma concentrations peaked at 1,207 ± 601 ng/ml and occurred at 3 ± 1 hr. The geometric mean of the apparent elimination half-life after oral administration was 8.3 ± 1.2 hr. This data suggests that flunixin meglumine appears to be slowly metabolized or slowly absorbed in this species. No adverse clinical effects were observed during the study period. A single dose of 1 mg/kg appears safe for use in the white rhinoceros. Multidose studies are needed to determine if plasma accumulation of flunixin meglumine occurs and to evaluate safety.

KW - 5-OH flunixin

KW - Ceratotherium simum

KW - flunixin meglumine

KW - pharmacokinetics

KW - white rhinoceros

UR - http://www.scopus.com/inward/record.url?scp=85067304055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067304055&partnerID=8YFLogxK

U2 - 10.1638/2018-0200

DO - 10.1638/2018-0200

M3 - Article

AN - SCOPUS:85067304055

VL - 50

SP - 322

EP - 329

JO - Journal of Zoo and Wildlife Medicine

JF - Journal of Zoo and Wildlife Medicine

SN - 1042-7260

IS - 2

ER -